Peptidyl Arginine Deiminases and Neurodegenerative Diseases

E-ISSN： 1875-533x|23|2|104-114

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.2, 2016-01, pp. : 104-114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation

Current Drug Targets, Vol. 16, Iss. 7, 2015-01 ,pp. : 700-710

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Peptidyl Prolyl Isomerases in Aging and Vascular Diseases

Current Molecular Pharmacology, Vol. 9, Iss. 2, 2015-12 ,pp. : 165-179

Bentham Science Publishers

Access to resources Recommend Favorite

Cholinergic receptors and neurodegenerative diseases

By Gualtieri F.

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 85-89

Elsevier

Access to resources Recommend Favorite

Chelating Agents for Neurodegenerative Diseases

Current Medicinal Chemistry, Vol. 19, Iss. 17, 2012-06 ,pp. : 2760-2772

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics of neurodegenerative diseases

By Maimone D. Dominici R. Grimaldi L.M.E.

European Journal of Pharmacology, Vol. 413, Iss. 1, 2001-02 ,pp. : 11-29

Elsevier

Access to resources Recommend Favorite